Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study

Risks and benefits of allergen immunotherapy

(2009) Barbara Rogala et al.   Expert Opinion On Drug Safety

Review article: From allergen genes to new forms of allergy diagnosis and treatment

(2008) S. Vrtala   ALLERGY

EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification

(2008) R. Van Ree et al.   ALLERGY

Different allergenic activity of grass pollen allergens revealed by skin testing

(2008) K. Westritschnig et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Local and Systemic Reactions Occurring During Immunotherapy: An Epidemiological Evaluation and a Prospective Safety-Monitoring Study

(2008) M.T. Ventura et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Specific Immunotherapy for Common Grass Pollen Allergies: Pertinence of a Five Grass Pollen Vaccine

(2008) Philippe Moingeon et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

(2008) James N. Francis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY